QUIDELORTHO CORP Increase (Decrease) in Inventories
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Inventories of $123.30 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in inventories for the quarter ending 2026-06-28 was $50.70M, a 2.42% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in inventories for the quarter ending 2026-03-29 was $72.60M, a 36.72% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in inventories for the quarter ending 2025-12-28 was $6.60M, a 71.55% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in inventories for the quarter ending 2025-09-28 was $39.10M, a 149.04% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in inventories for fiscal 2025 was $148.30M, a 10.59% increase from fiscal 2024.
- QUIDELORTHO CORP increase (decrease) in inventories for fiscal 2024 was $134.10M, a 36.63% decline from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in inventories for fiscal 2023 was $211.60M, a 81.01% increase from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in inventories for fiscal 2023 was $116.90M, a 37.53% increase from fiscal 2022.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-28 | $50.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $123.30M 10-Q · filed 2026-08-07 | $129.90M derived: sum of 3 quarters · filed 2026-08-07 | $169.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $72.60M 10-Q · filed 2026-05-06 | $79.20M derived: sum of 2 quarters · filed 2026-05-06 | $118.30M derived: sum of 3 quarters · filed 2026-05-06 | $167.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $45.70M derived: sum of 2 quarters · filed 2026-02-19 | $95.20M derived: sum of 3 quarters · filed 2026-08-07 | $148.30M 10-K · filed 2026-02-19 |
| 2025-09-28 | $39.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $88.60M derived: sum of 2 quarters · filed 2026-08-07 | $141.70M 10-Q · filed 2025-11-06 | $164.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $49.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $102.60M 10-Q · filed 2026-08-07 | $125.80M derived: sum of 3 quarters · filed 2026-08-07 | $141.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $53.10M 10-Q · filed 2026-05-06 | $76.30M derived: sum of 2 quarters · filed 2026-05-06 | $92.00M derived: sum of 3 quarters · filed 2026-05-06 | $149.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $23.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.90M derived: sum of 2 quarters · filed 2026-02-19 | $96.40M derived: sum of 3 quarters · filed 2026-02-19 | $134.10M 10-K · filed 2026-02-19 |
| 2024-09-29 | $15.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $73.20M derived: sum of 2 quarters · filed 2025-11-06 | $110.90M 10-Q · filed 2025-11-06 | $176.50M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $57.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $95.20M 10-Q · filed 2025-08-06 | $160.80M derived: sum of 3 quarters · filed 2026-02-19 | $220.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $37.70M 10-Q · filed 2025-05-08 | $103.30M derived: sum of 2 quarters · filed 2026-02-19 | $163.30M derived: sum of 3 quarters · filed 2026-02-19 | $212.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $65.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $125.60M derived: sum of 2 quarters · filed 2026-02-19 | $174.30M derived: sum of 3 quarters · filed 2026-02-19 | $211.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | $60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $108.70M derived: sum of 2 quarters · filed 2024-11-08 | $146.00M 10-Q · filed 2024-11-08 | $165.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $48.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $86.00M 10-Q · filed 2024-08-01 | $105.00M derived: sum of 3 quarters · filed 2025-02-27 | $166.80M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $37.30M 10-Q · filed 2024-05-09 | $56.30M derived: sum of 2 quarters · filed 2025-02-27 | $118.10M derived: sum of 3 quarters · filed 2025-02-27 | $171.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $80.80M derived: sum of 2 quarters · filed 2025-02-27 | $134.20M derived: sum of 3 quarters · filed 2025-02-27 | $116.90M 10-K · filed 2025-02-27 |
| 2022-10-02 | $61.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $115.20M derived: sum of 2 quarters · filed 2023-11-02 | $97.90M 10-Q · filed 2023-11-02 | $99.60M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $53.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $36.10M 10-Q · filed 2023-08-09 | $37.80M derived: sum of 3 quarters · filed 2024-08-01 | $16.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | -$17.30M 10-Q · filed 2023-05-04 | -$15.60M derived: sum of 2 quarters · filed 2024-08-01 | -$37.10M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $1.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | -$19.80M derived: sum of 2 quarters · filed 2024-08-01 | $85.00M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | -$21.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $83.30M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $104.80M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $54.90M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |